Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3312264 | Journal de Chirurgie Viscérale | 2011 | 13 Pages |
Abstract
Pancreatic ductal adenocarcinoma represents 90% of pancreatic cancers and the fifth cause of cancer death in Western countries. Overall survival rate at 5 years is less than 5%. Surgical resection is still the only treatment providing prolonged survival but, even after a curative resection, 5-year survival rates are low. However, some patients have a slower tumor progression and median survival increased due to treatment advances and better patient selection. The objective of this review is to analyze the prognostic factors related to patient, treatment and tumor, to identify those associated with better long-term survival after resection of pancreatic adenocarcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
C. Neuzillet, A. Sauvanet, P. Hammel,